SNN

Smith & Nephew plc

Stock NYSE – Stock Market Prices, News & Analysis

Smith & Nephew is a company that develops and markets advanced medical devices used primarily in orthopedics, trauma, and surgery.

$ 31.54
1.45 %

Smith & Nephew plc

$ 31.54
1.45 %
SNN

Smith & Nephew is a company that develops and markets advanced medical devices used primarily in orthopedics, trauma, and surgery.

Price history of Smith & Nephew plc
Price history of Smith & Nephew plc

Performance & Momentum

6 Months 12.51 %
1 Year 19.55 %
3 Years 7.11 %
5 Years 16.65 %

Strategic Analysis

Smith & Nephew plc • 2026

Smith & Nephew plc is a global medical devices company with a strong presence in orthopaedics, traumatology and surgery. Its positioning is based on specialized, high clinical value solutions in a market supported by ageing populations and demand for more efficient hospital equipment.

Strengths
  • Recognized expertise in surgical and orthopaedic medical devices
  • Exposure to structural and recurring healthcare needs
  • Specialized product portfolio that allows it to stand out through technical sophistication and clinical use
Weaknesses
  • Sensitivity to hospital investment cycles and healthcare budgets
  • Uneven long-term stock performance, reflecting sometimes inconsistent execution
Momentum

Momentum appears satisfactory and constructive, without any sign of overheating. The recent trend is supported by a visible improvement over the past year, but the more recent pullback calls for caution and suggests a consolidation phase rather than a clear acceleration. Strategically, the stock retains a high-quality defensive profile, but its rerating will depend on more consistent execution and better visibility on growth.

Similar stocks to Smith & Nephew plc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone